Trial Details
COMPLETEDBasic Information
| Clinical ID | c4709 |
|---|---|
| Identifier | NCT00088062 |
| Trial Title | STA-5326 in Crohn's Disease Patients |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: STA-5326 |
Participant Information
| Sponsor | Synta Pharmaceuticals Corp. |
|---|---|
| City | Tucson |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2004-02 |
|---|---|
| Primary Completion Date | - |
| Completion Date | 2004-11 |